Business Segments Otsuka Holdings Co., Ltd.

Equities

Market Closed - Japan Exchange Other stock markets 06:30:00 10/02/2026 GMT			5-day change	1st Jan Change
9,857.00 ^JPY	+2.56%		+5.15%	+11.09%

02-04	Biodexa announces exclusive license of Otsuka's OPB-171775, a potent phase 1 ready molecular glue for GIST	RE
02-04	HBM Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2025	CI

See more © MarketScreener.com

See more © MarketScreener.com

Breakdown by Business Segment (JPY)

Fiscal Period: December	2020	2021	2022	2023	2024
Pharmaceutical Products
Pharmaceuticals	955B	978B	1,138B	1,364B	1,629B
Total Assets	-	-	-	-	-
CAPEX	-	-93.62B	-101B	-	-
D&A	-	55.72B	62.18B	-	72.81B
Operating Income	197B	137B	123B	278B	285B
Vitamins and Nutritional Supplements
Nutraceuticals	334B	377B	437B	483B	557B
Total Assets	-	-	-	-	-
CAPEX	-	-19.6B	-15.01B	-	-
D&A	-	14.5B	15.65B	-	20.73B
Operating Income	41.99B	46.56B	56.28B	59.65B	59.78B
Warehousing and Storage
Others	140B	150B	169B	134B	114B
Total Assets	-	-	-	-	-
CAPEX	-	-10.74B	-9.26B	-	-
D&A	-	8.58B	8.79B	-	5.84B
Operating Income	10.45B	11.44B	11.92B	7.72B	7.52B
Bottled Water
Consumer Products	31.36B	31.92B	35.88B	37.07B	33.76B
Total Assets	-	-	-	-	-
CAPEX	-	-2.67B	-3.32B	-	-
D&A	-	1.61B	1.8B	-	2.09B
Operating Income	10.64B	5.31B	6.93B	17.82B	23B
Unallocated Adjustment	-37.89B	-37.79B	-42.01B	-	-3.63B
Total Assets	-	-	-	-	-
CAPEX	-	-17.47B	-10.7B	-	-
D&A	-	4.44B	5.34B	-	6.51B
Operating Income	-43.38B	-	-	-	-
Operating Income	-	329M	-265M	-	-530M
Operating Income	-	-47.36B	-48.99B	-	-55.82B
Operating Income	-	874M	1.31B	-	4.5B

Geographical breakdown of sales (JPY)

Fiscal Period: December	2020	2021	2022	2023	2024
North America	-	510B	684B	873B	1,095B
Total Assets	-	640B	723B	-	882B
Japan	-	647B	655B	671B	700B
Total Assets	-	491B	523B	-	521B
Others	-	185B	227B	256B	292B
Total Assets	-	65.92B	71.96B	-	96.08B
Europe	-	157B	173B	219B	243B
Total Assets	-	111B	114B	-	134B
U.S.	-	-	-	-	-
Total Assets	-	-	-	-	-